M.D. Sass LLC Has $858,000 Stock Position in Option Care Health, Inc. (NASDAQ:OPCH)

M.D. Sass LLC decreased its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 40.3% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 27,413 shares of the company’s stock after selling 18,500 shares during the quarter. M.D. Sass LLC’s holdings in Option Care Health were worth $858,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. CANADA LIFE ASSURANCE Co raised its position in shares of Option Care Health by 1.8% during the 1st quarter. CANADA LIFE ASSURANCE Co now owns 134,305 shares of the company’s stock valued at $4,503,000 after acquiring an additional 2,355 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its stake in Option Care Health by 1.4% in the first quarter. Price T Rowe Associates Inc. MD now owns 1,760,482 shares of the company’s stock valued at $59,047,000 after buying an additional 23,676 shares during the period. Janus Henderson Group PLC lifted its stake in Option Care Health by 182.9% in the first quarter. Janus Henderson Group PLC now owns 227,135 shares of the company’s stock valued at $7,617,000 after buying an additional 146,837 shares during the period. Tidal Investments LLC boosted its holdings in Option Care Health by 74.2% during the first quarter. Tidal Investments LLC now owns 13,460 shares of the company’s stock worth $451,000 after buying an additional 5,733 shares during the last quarter. Finally, Comerica Bank grew its position in shares of Option Care Health by 6.5% during the 1st quarter. Comerica Bank now owns 760,915 shares of the company’s stock worth $25,521,000 after buying an additional 46,639 shares during the period. 98.05% of the stock is owned by institutional investors.

Option Care Health Stock Performance

Shares of Option Care Health stock remained flat at $23.40 during trading on Tuesday. The stock had a trading volume of 218,908 shares, compared to its average volume of 1,535,331. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $34.63. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The business’s 50 day simple moving average is $27.45 and its two-hundred day simple moving average is $29.05. The company has a market cap of $3.98 billion, a P/E ratio of 19.66, a price-to-earnings-growth ratio of 2.39 and a beta of 1.32.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on the stock. Bank of America lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and reduced their price objective for the stock from $43.00 to $29.00 in a research note on Wednesday, October 30th. Jefferies Financial Group lowered shares of Option Care Health from a “buy” rating to a “hold” rating and decreased their price target for the company from $38.00 to $26.00 in a report on Thursday, October 31st. JMP Securities upped their price objective on shares of Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a research report on Monday, September 30th. Barrington Research decreased their target price on Option Care Health from $40.00 to $32.00 and set an “outperform” rating for the company in a research note on Thursday, October 31st. Finally, Truist Financial dropped their price target on Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research report on Friday, November 1st. Three equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, Option Care Health presently has a consensus rating of “Moderate Buy” and an average price target of $30.83.

Insider Transactions at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of the firm’s stock in a transaction dated Friday, November 8th. The stock was bought at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the acquisition, the director now directly owns 326,334 shares of the company’s stock, valued at approximately $7,355,568.36. The trade was a 15.18 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.64% of the stock is currently owned by insiders.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.